Estimation of progression-free survival in the randomized discontinuation trial design
- PMID: 23319693
- DOI: 10.1200/JCO.2012.46.1087
Estimation of progression-free survival in the randomized discontinuation trial design
Comment in
-
Reply to T.G. Karrison.J Clin Oncol. 2013 Feb 20;31(6):814-5. doi: 10.1200/JCO.2012.46.4826. J Clin Oncol. 2013. PMID: 23544201 No abstract available.
Comment on
-
Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma.J Clin Oncol. 2012 May 10;30(14):1678-85. doi: 10.1200/JCO.2011.35.3524. Epub 2012 Apr 9. J Clin Oncol. 2012. PMID: 22493422 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical